A new three-dimensional mammogram device purported by the device maker Hologic to more precisely detect breast lesions and reduce the number of follow-up breast cancer screenings, when used in conjunction with conventional digital mammograms, cleared an FDA hurdle Monday.
3D mammogram on brink of FDA approval
"This is a major advance that we have been working on for years," said Dr. Daniel Kopans, director of the breast imaging center at Massachusetts General Hospital in Boston, which holds the patent to the device. "It will aid in detecting more cancers earlier, and reduce the false positive callbacks."
Source: ABC News
U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.